摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure-hydrochlorid | 94695-73-5

中文名称
——
中文别名
——
英文名称
1-Cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure-hydrochlorid
英文别名
1-cyclopropyl-6,8-difluoro-7-(piperazin-1-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride;1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid hydrochloride;1-cyclopropyl-6,8-difluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrochloride
1-Cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure-hydrochlorid化学式
CAS
94695-73-5
化学式
C17H17F2N3O3*ClH
mdl
——
分子量
385.798
InChiKey
GVULYMMWMDGQEW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.14
  • 重原子数:
    26
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    72.9
  • 氢给体数:
    3
  • 氢受体数:
    8

反应信息

点击查看最新优质反应信息

文献信息

  • Immunostimulating agents
    申请人:Bayer Aktiengesellschaft
    公开号:US04659603A1
    公开(公告)日:1987-04-21
    1-Cyclopropylquinolone-3-carboxylic acids of the formula ##STR1## in which R.sup.1 is hydrogen, methyl, ethyl or .beta.-hydroxyethyl, and R.sup.2 is hydrogen, chlorine or fluorine or salts thereof stimulate the immune system, especially in conjunction with an antigen.
    公式为##STR1##的1-环丙基喹诺酮-3-羧酸中,其中R.sup.1为氢、甲基、乙基或β-羟乙基,R.sup.2为氢、或其盐,可刺激免疫系统,特别是与抗原一起使用。
  • 7-Amino-1-cyclopropyl-6,8-difluoro-1,4-di
    申请人:Bayer Aktiengesellschaft
    公开号:US04556658A1
    公开(公告)日:1985-12-03
    The invention relates to 7-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxyli c acids, processes for their preparation and compositions containing them as antibacterial agents. Also included in the invention are methods for treating bacterial infection using the compounds and compositions of the invention.
    本发明涉及7-基-1-环丙基-6,8-二-1,4-二氢-4-氧基-喹啉-3-羧酸、其制备方法及包含它们作为抗菌剂的组合物。本发明还包括使用本发明的化合物和组合物治疗细菌感染的方法。
  • Cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic
    申请人:Bayer Aktiengesellschaft
    公开号:US04952695A1
    公开(公告)日:1990-08-28
    1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and ester as pharmaceutical intermediate.
    1-环丙基-6,7,8-三-1,4-二氢-4-氧喹啉-3-羧酸和酯作为药物中间体。
  • Novel quinolinecarboxylic acid compounds, processes for preparing them, pharmaceutical composition and use
    申请人:KANEBO, LTD.
    公开号:EP0220523A2
    公开(公告)日:1987-05-06
    Novel compounds of the formula: wherein R is ethyl, 2-fluoroethyl or cyclopropyl, and X is hydrogen atom of fluorine atom, and a pharmaceutically acceptable salt thereof, which have excellent antimicrobial activities in vivo and hence are useful as an antimicrobial agent, and a pharmaceutical composition containing said compound as an active ingredient, processes for the preparation of the compounds, and their use in the preparation of an antimicrobial medicament are disclosed.
    式的新型化合物: 其中 R 是乙基、2-乙基或环丙基,X 是氢原子或原子,公开了其药学上可接受的盐,它们在体内具有优异的抗菌活性,因此可用作抗菌剂,还公开了含有上述化合物作为活性成分的药物组合物、化合物的制备工艺及其在制备抗菌药物中的用途。
  • GROHE K.; HEITZER H. H., LIEBIGS ANN. CHEM.,(1987) N 1, 29-37
    作者:GROHE K.、 HEITZER H. H.
    DOI:——
    日期:——
查看更多